Does type of bone graft matter? A retrospective review of the use of biological bone grafts in patients undergoing elective 1–3 level spinal interbody fusion
European Spine Journal · 2024
DOI: 10.1007/s00586-023-08108-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Spine Journal, 2024. Verfasst von Daniel Zeitouni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Atrium Health Neurological Surgery, Charlotte, NC, USA. daniel.zeitouni@cnsa.com. Hauptthemen laut MEDLINE: Spinal Fusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: There is a lack of strong evidence for use of expensive bone substitutes. This study compares perioperative data and patient reported quality-of-life outcomes across the varied types of bone graft extenders. The study analyzes the existing Quality and Outcomes Database and evaluates patient reported outcomes for 1-3 level lumbar fusion procedures comparing across different types of biologics bone graft. METHODS: We retrospectively analyzed a prospectively collected data registry. Bone graft implant data were collected and grouped into the following categories: (1) Autograft with basic allograft (2) Enhanced, synthetic, or cellular allograft (3) Use of BMP. Preoperative and 1 year patient reported outcomes and perioperative data from the prospective collected registry were analyzed. RESULTS: There were 384 patients included in this study. There were 168 (43.8%) patients in group 1, 133 (34.6%) patients in group 2, and 83 (21.6%) in group 3. There were no group differences in baseline or 1 year back pain, leg pain, ODI, or EQ-5D. The GLM Repeated Measures results indicate a significant difference within each of the three groups between the preoperative and postoperative measures for back pain, leg pain, ODI, and EQ-5D. The change over time was not significantly different between the groups. CONCLUSIONS: Bone graft extenders are a significant contributor to the cost of lumbar fusion. This study demonstrates no difference in preoperative, and 1 year patient reported outcomes between the three groups. There was no significant difference in rate of reoperations across the three groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Atrium Health Neurological Surgery, Charlotte, NC, USA. daniel.zeitouni@cnsa.com.
- Carolina Neurosurgery and Spine Associates, 225 Baldwin Ave, Charlotte, NC, 28203, USA. daniel.zeitouni@cnsa.com.
- Carolina Neurosurgery and Spine Associates, 225 Baldwin Ave, Charlotte, NC, 28203, USA.
- Atrium Health Neurological Surgery, Charlotte, NC, USA.
ORCID-Profile: Daniel Zeitouni
Zitieren
APA
Zeitouni, D., Pfortmiller, D., Coric, D., Kim, P. K., Smith, M. D., Dyer, E. H., Adamson, T. E., McGirt, M. J., & Rossi, V. J. (2024). Does type of bone graft matter? A retrospective review of the use of biological bone grafts in patients undergoing elective 1–3 level spinal interbody fusion. European Spine Journal. https://doi.org/10.1007/s00586-023-08108-2
Vancouver
Zeitouni D, Pfortmiller D, Coric D, Kim PK, Smith MD, Dyer EH, et al. Does type of bone graft matter? A retrospective review of the use of biological bone grafts in patients undergoing elective 1–3 level spinal interbody fusion. European Spine Journal. 2024. doi:10.1007/s00586-023-08108-2
BibTeX
@article{Zeitouni2024,
author = {Zeitouni, Daniel and Pfortmiller, Deborah and Coric, Domagoj and Kim, Paul K and Smith, Mark D and Dyer, E Hunter and Adamson, Tim E and McGirt, Matthew J and Rossi, Vincent J},
title = {Does type of bone graft matter? A retrospective review of the use of biological bone grafts in patients undergoing elective 1–3 level spinal interbody fusion},
journal = {European Spine Journal},
year = {2024},
doi = {10.1007/s00586-023-08108-2}
}
EUVIMED